BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2022-00619 Novel Long Acting Injectable Antiretrovirals: Real-Life Therapeutic Drug Concentration Monitoring in Switzerland non clinical, involving persons multicentric A Prof Matthias Cavassini CHUV CHUV, Lausanne
HUG, Geneva
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Commission Cantonale d'éthique de la recherche Genève (CCER) 14.07.2022
2022-00618 Automatische und patientenspezifische 3D-MRT-Modelle von Hüftknochen, Hüftknorpel und Labrum für verbesserte chirurgische Entscheidungsfindung personal data/biological material monocentric PD Dr. med. Simon D. Steppacher Inselspital Bern Department für Orthopädie und Traumatologie, Inselspital Bern, Bern
Kantonale Ethikkommission Bern 13.05.2022
2022-00616 Harnessing the beneficial non-specific effects of measles-mumps-rubella vaccine on infection with unrelated pathogens and allergic diseases in children – a single-centre phase IV randomised controlle More ... clinical trial drugs phase 4 monocentric A Dr Laure PITTET University Hospital of Geneva University Hospitals of Geneva, Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 19.05.2022 yes
2022-00615 ‘Quality of life evaluation for patients with rectal cancer having undergone sphincter sparing surgery: evaluation of the low anterior resection syndrome (LARS)’ non clinical, involving persons monocentric A Prof. Bernhard Egger HFR Cantonal Hospital of Fribourg Department of general surgery, HFR Cantonal Hospital, Fribourg
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 30.09.2022
2022-00614 Comparaison du Bioactive Glass avec d’autres substituts osseux : autogreffe, allogreffe et antibiotiques locaux dans le traitement des pseudarthroses et ostéomyélites : une étude rétrospective. personal data/biological material monocentric MD, PD, MERc Sylvain Steinmetz CHUV CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 26.04.2022
2022-00613 A randomized, placebo-controlled, double-blind, monocenter, phase II trial to assess the efficacy of Calcium Dobesilate (CaD) vs. placebo on SARS-CoV-2 viral load amongst outpatients with COVID-19 clinical trial drugs phase 2 monocentric B MD Hervé Spechbach Hôpitaux universitaire de Genève (HUG) Hôpitaux universitaire de Genève (HUG), Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 17.05.2022 yes
2022-00611 Geschlechterspezifische Unterschiede in den Ursachen von Synkopen personal data/biological material monocentric PD Dr. med. Dr. phil. Ksenija Slankamenac Institut für Notfallmedizin Institut für Notfallmedizin, Zürich
Kantonale Ethikkommission Zürich 08.04.2022 Study has ended
2022-00610 Biological behavior of sparsely and densely granulated GH secreting pituitary adenomas: a retrospective observational study of surgical series personal data/biological material monocentric Dr Giulia Cossu CHUV CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 28.04.2022
2022-00609 Comparison Of Accuracy Of Conventional Plating Vs. Intercus Plate In CARD Opening-Wedge Osteotomies Of Distal Radius Malunion personal data/biological material monocentric Prof. Dr. med. Anderas Schweizer Universitätsklinik Balgrist Universitätsklinik Balgrist, Zürich
Kantonale Ethikkommission Zürich 12.04.2022
2022-00608 A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemi More ... clinical trial drugs phase 2 multicentric C Prof. Dr. Britta Maurer Horizon Therapeutics Ireland DAC Inselspital Bern Anna Seiler Haus, Stock A Zimmer 315, Freiburgstrasse 18, 3010 Bern, Bern
Kantonsspital St. Gallen, Klinik für Rheumatologie, St. Gallen
HFR Fribourg - Hôpital cantonal, Department of More ...
Kantonale Ethikkommission Bern Ethikkommission Ostschweiz (EKOS), Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 28.11.2022
2022-00607 Efficacy of an unguided or guided app-based psychosocial intervention to enhance quality of life in Arabic-speaking refugees residing in Switzerland:
A randomized controlled trial
clinical trial other clinical trials monocentric A Prof. Dr. Thomas Berger Universität Bern University of Bern, Institute of Psychology, Bern
Kantonale Ethikkommission Bern 08.08.2022
2022-00606 Personalized IMMUNOtherapy in SEPsis: A multicentre and multinational, double-blind, double-dummy randomized clinical trial clinical trial drugs phase 2 monocentric C Prof. Thierry Calandra Hellenic Institute for the Study of Sepsis CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 01.06.2022
2022-00605 SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrozole plus Palbociclib for the Treatment of Patients with Estrogen Receptor-P More ... clinical trial drugs phase 3 multicentric C PD Dr. med Marcus Vetter AstraZeneca AB Kantonsspital Baselland, Onkologie Hämatologie & Immuntherapie, 4410 Liestal
Inselspital, Universitätsspital Bern, Freiburgstrasse 15, 3010 Bern
Brust-Zentrum Zürich, Onkologie, Zürich
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich 20.07.2022
2022-00604 Controllability and the interoception of breathing (CITRO) non clinical, involving persons monocentric A Dr. Sandra Iglesias, PhD UZH & ETHZ, Institut für Biomedizinische Technik, Translational Neuromodeling Unit Translational Neuromodeling Unit, Zurich
Kantonale Ethikkommission Zürich 06.05.2022
2022-00603 SASCIA - Phase III postneoadjuvant study evaluating Sacituzumab Govitecan, an Antibody Drug Conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant More ... clinical trial drugs phase 3 multicentric C Dr. med. Ursina Zürrer GBG (German Breast Group) Kantonsspital Winterthur, Winterthur
Brustzentrum, University Hospital Basel, Basel
Kantonsspital St. Gallen, St. Gallen
Brustzentrum Zürich, Zürich
Kantonsspital Graubünden, Chur
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich 24.06.2022
2022-00602 A brief report of an interesting bone marrow finding in systemic mastocytosis personal data/biological material monocentric Dr Vasiliki Papadopoulou CHUV CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 07.04.2022 Study has ended
2022-00600 Phase IIb, randomized, double-blind, placebo-controlled study in
parallel groups assessing the efficacy and safety of two doses of
SOM3355 in patients suffering from Huntington’s Disease with
ch More ...
clinical trial drugs phase 2 monocentric C Michael Orth SOM Innovation Biotech S.A. Neurozentrum Siloah, Gumlingen
Kantonale Ethikkommission Bern 03.02.2023
2022-00597 Evaluation of molecular and Next Generation Sequencing approaches for SARS-CoV-2 identification and characterization in clinical samples personal data/biological material monocentric PD Dr. Alban Ramette University of Bern University of Bern, Bern
Kantonale Ethikkommission Bern 15.09.2022
2022-00595 Streptococcus bovis bacteraemia : metastatic malignancies in the gut are also a gateway personal data/biological material monocentric Sylvain Meylan CHUV CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 19.04.2022 Study has ended
2022-00594 Fontan-associated Liver Disease (FALD): laboratory, clinical, histological and imaging characteristics of a Swiss, single-centre, adult cohort personal data/biological material monocentric Prof. Annalisa Berzigotti UVCM, Hepatology UVCM, Inselspital, Bern
Kantonale Ethikkommission Bern 09.12.2022